Tag: Calyxt

Agriculturally advantaged traits: The Digest’s 2017 Multi-Slide Guide to Calyxt

Agriculturally advantaged traits: The Digest’s 2017 Multi-Slide Guide to Calyxt

October 9, 2017 |

Calyxt is pioneering a paradigm shift to deliver both healthier specialty food ingredients, such as healthier oils and high fiber wheat for consumers as well as agriculturally advantageous traits, such as herbicide tolerance to farmers. The technology enables Calyxt to precisely and specifically edit a plant genome to elicit the desired traits and characteristics, resulting […]

Read More

A Blustery Day in the Bioeconomy’s Billion Acre Wood: The Latest from EPA, POET, Fuels America, Calyxt, Eligo Bioscience, Queensland, Gevo, Virgin, and Unilever

A Blustery Day in the Bioeconomy’s Billion Acre Wood: The Latest from EPA, POET, Fuels America, Calyxt, Eligo Bioscience, Queensland, Gevo, Virgin, and Unilever

October 3, 2017 |

British author AA Milne is in the news this week with the impending release of “Goodbye Christopher Robin,” which brings to mind “Winnie the Pooh and the Blustery Day”. It’s been bluster and bother and in the bioeconomy this week, all right, and significant players are feeling downright Eeyoreish and we’ll get to that. But some […]

Read More

IPO market re-opens, sort of, as Calyxt raises $56M in NASDAQ offering

IPO market re-opens, sort of, as Calyxt raises $56M in NASDAQ offering

July 20, 2017 |

In Minnesota, Calyxt, the gene editing agriculture company, raised $56M and priced its NASDAQ initial public offering of 7 million shares at $8.00. The number of shares in the offering was sweetened to 7 million this week, from the original estimate of 6.06 million — and the price was substantially lower than the expected $15.00-$18.00 […]

Read More

Calyxt files for $109M IPO: The Digest’s 5-Minute Version

Calyxt files for $109M IPO: The Digest’s 5-Minute Version

July 13, 2017 |

A technology unlocking value in agriculture through accelerated breeding comes to the public markets. No time to read the 101,000 words on the complete IPO filing? Here’s our 5-minute version, with a translation of the risks into English. In Minnesota, Calyxt has filed an S-1 registration statement for a proposed $109 million initial public offering.  The […]

Read More

Frontiers of gene-editing, and why Calyxt is one to watch

Frontiers of gene-editing, and why Calyxt is one to watch

April 9, 2017 |

This past week, in highlighting 29 technologies to watch, we put a spotlight on Calyxt, and we’d like to return to that technology in more depth today — as we look at real disruptive change not only in technology but in consumer attitudes, and buying patterns. Let’s explore that technology and company in more detail […]

Read More